Public health officials in England have identified a new variant of mpox, the viral disease related to smallpox, following detailed genetic sequencing that revealed mutations not seen in previously circulating strains.
The UK Health Security Agency (UKHSA) said the variant shows changes in parts of the virus’s genetic code linked to viral replication and interactions with the human immune system, prompting closer monitoring of its potential implications.
The case that led to the identification involved a traveller who had recently returned to the UK from Asia. Laboratory testing confirmed mpox infection, and subsequent genomic sequencing revealed a distinct genetic profile, leading scientists to classify it as a new variant. UKHSA said it is working with international public health and research partners to assess how widely the variant may be circulating globally and whether it behaves differently from earlier strains.
Researchers are examining whether the mutations could influence transmissibility, severity of illness, or the effectiveness of existing vaccines and treatments, though there is currently no evidence of increased risk. Mpox typically causes symptoms such as fever, rash and swollen lymph nodes, and most cases resolve without severe complications.
Since mpox outbreaks were detected outside Africa in recent years, health authorities have significantly expanded surveillance and genomic sequencing efforts.
UKHSA emphasised that ongoing monitoring of viral evolution is essential to detect changes early and guide public health responses. Officials continue to urge vigilance, timely testing and appropriate precautions while more data is gathered on the characteristics and public health impact of the newly detected variant.
Also Read